Dudley H McNitt

Title: The Innovations of Dudley H McNitt

Introduction

Dudley H McNitt is an accomplished inventor based in Morgantown, WV (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of recombinant collagen-like proteins. His work focuses on targeting tumor microenvironments, which is crucial for advancing cancer therapies.

Latest Patents

Dudley H McNitt holds a patent for "Targeting tumor microenvironments with recombinant prokaryotic collagen-like proteins." This patent describes a recombinant collagen-like protein that includes a binding domain capable of interacting with both extra domain A and extra domain B-containing variants of cellular fibronectin. The application of this recombinant collagen-like protein offers a promising method for treating cancer by administering it to patients.

Career Highlights

Dudley H McNitt is affiliated with West Virginia University, where he continues to engage in groundbreaking research. His work has garnered attention for its potential to improve cancer treatment outcomes. With a focus on innovative solutions, he has established himself as a key figure in his field.

Collaborations

Dudley collaborates with Slawomir Lukomski, enhancing the research efforts at West Virginia University. Their partnership exemplifies the importance of teamwork in advancing scientific discoveries.

Conclusion

Dudley H McNitt's contributions to cancer treatment through his innovative patent highlight the potential of recombinant proteins in medical applications. His work at West Virginia University continues to pave the way for future advancements in the field.